Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Neuromelanin granules (NMGs) are the characteristic hallmark of the human substantia nigra pars compacta (SNpc). Although especially NMG-containing neurons are affected by neurodegeneration in Parkinson's disease (PD), the complex biology of NMGs is not fully understood. This is partly due to the limitation that classical animal model systems do not produce NMGs. In this review, we summarize the plethora of animal models used to investigate NMG formation. While these models have already contributed to our knowledge about pathomechanisms in PD, especially in strengthening the interplay between lysosomal dysfunction, accumulation of NMGs and degeneration of dopaminergic neurons, open questions remain. However, new animal models combining NMG formation and PD-like pathology promise to offer immense value for studies on novel therapeutic approaches for PD.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.